Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen W Scotto

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Anti-Cancer Drugs|August 14, 2002
ET-743: more than an innovative mechanism of actionKathleen W Scotto
Oncogene|October 25, 2003
Transcriptional regulation of ABC drug transportersKathleen W Scotto
The Journal of Biological Chemistry|March 31, 2015
Methylxanthines Increase Expression of the Splicing Factor SRSF2 by Regulating Multiple Post-transcriptional MechanismsJia Shi, Kirk Pabon, Kathleen W Scotto
Molecular and Cellular Biology|November 21, 2007
Caffeine regulates alternative splicing in a subset of cancer-associated genes: a role for SC35Jia Shi, Zhen Hu, Kirk Pabon, et al.
Molecular Pharmacology|November 25, 2011
Xanthines down-regulate the drug transporter ABCG2 and reverse multidrug resistanceRui Ding, Jia Shi, Kirk Pabon, et al.
Autophagy|March 18, 2016
A role for ABCG2 beyond drug transport: Regulation of autophagyRui Ding, Shengkan Jin, Kirk Pabon, et al.
The Journal of Biological Chemistry|January 7, 2005
Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domainRobert A Johnson, Erica M Shepard, Kathleen W Scotto
The Journal of Biological Chemistry|April 19, 2024
ABCG2 and SLC1A5 functionally interact to rewire metabolism and confer a survival advantage to cancer cells under oxidative stressJia Shi, Kirk Pabon, Rui Ding, et al.
Biochemical Pharmacology|July 31, 2007
Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cellsWei Jin, Kathleen W Scotto, William N Hait, et al.
Oncotarget|February 6, 2016
MTHFD2--a new twist?Philip M Tedeschi, Kathleen W Scotto, John Kerrigan, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Anti-Cancer Drugs|August 14, 2002
ET-743: more than an innovative mechanism of actionKathleen W Scotto
Oncogene|October 25, 2003
Transcriptional regulation of ABC drug transportersKathleen W Scotto
The Journal of Biological Chemistry|March 31, 2015
Methylxanthines Increase Expression of the Splicing Factor SRSF2 by Regulating Multiple Post-transcriptional MechanismsJia Shi, Kirk Pabon, Kathleen W Scotto
Molecular and Cellular Biology|November 21, 2007
Caffeine regulates alternative splicing in a subset of cancer-associated genes: a role for SC35Jia Shi, Zhen Hu, Kirk Pabon, et al.
Molecular Pharmacology|November 25, 2011
Xanthines down-regulate the drug transporter ABCG2 and reverse multidrug resistanceRui Ding, Jia Shi, Kirk Pabon, et al.
Autophagy|March 18, 2016
A role for ABCG2 beyond drug transport: Regulation of autophagyRui Ding, Shengkan Jin, Kirk Pabon, et al.
The Journal of Biological Chemistry|January 7, 2005
Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domainRobert A Johnson, Erica M Shepard, Kathleen W Scotto
The Journal of Biological Chemistry|April 19, 2024
ABCG2 and SLC1A5 functionally interact to rewire metabolism and confer a survival advantage to cancer cells under oxidative stressJia Shi, Kirk Pabon, Rui Ding, et al.
Biochemical Pharmacology|July 31, 2007
Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cellsWei Jin, Kathleen W Scotto, William N Hait, et al.
Oncotarget|February 6, 2016
MTHFD2--a new twist?Philip M Tedeschi, Kathleen W Scotto, John Kerrigan, et al.
Pageof 3